Brief: Wilex Q1 sales revenue and income up at 1.0 mln euros

Heidelberg Pharma AG

14/04/2016 06:10

April 14 (Reuters) - Wilex AG  WL6G.DE : 
    * Q1 sales revenue and income totalling 1.0 million euros  
($1.13 million), up 11 pct on previous year (0.9 million euros) 
    * Q1 research and development costs of 1.3 million euros 
were up 0.5 mln euros on prior-year period (0.8 mln euros), due 
to expansion of preclinical investigations at Heidelberg Pharma 
    * At 1.1 million euros, Wilex group's net loss for first 
three months of financial year was maintained at a stable level 
compared with previous year 
    * Total assets as of Feb. 29, 2016 amounted to 13.0 mln 
euros, up from figure of 12.1 mln euros shown as of Nov. 30, 
2015 reporting date 
 
Source text for Eikon:  ID:nEQ4ZZWHqa  
Further company coverage:  WL6G.DE  
 
($1 = 0.8879 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 39 20;))